Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiao Huozhu Granules is a Traditional Chinese Medicine (TCM) formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically designed for the treatment of gastrointestinal-type common cold characterized by external heat-dampness syndrome and gastrointestinal disharmony. The formulation likely combines elements of the classic wind-heat clearing formula 'Yinqiao' with dampness-resolving and stomach-harmonizing ingredients (potentially Agastache and Atractylodes, as suggested by the name 'Huozhu'). It is currently being evaluated in clinical trials in China to assess its clinical efficacy and safety compared to standard treatments such as Huoxiang Zhengqi Soft Capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinqiao Huozhu Granules.